Name
Bortezomib
Alternate Names
LDP-341
MLN-341
PS-341
Velcade
Abbreviations
None
Category
Chemotherapy
Subcategory
Proteasome Inhibitor
NSC Number
681239
Primary Site
Histology
None
Remarks
November 14, 2014 update: FDA approved to treat multiple myeloma and Mantle cell lymphoma. In clinical trials for breast, colorectal, and lung cancer.
Coding
This drug should be coded